A longitudinal study of serial BODE indices in predicting mortality and readmissions for COPD

Respiratory Medicine

Volumn 105, Issue 2, 2011, Pages 266-273

  Ko, Fanny W S ^a   Tam, Wilson ^b   Tung, Alvin H M ^a   Ngai, Jenny ^a   Ng, Susanna S S ^a   Lai, Kenneth ^a   Au, Ka Fai ^c   Hui, David S C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c KWONG WAH HOSPITAL   (Hong Kong)

Author keywords

COPD; Mortality; Readmissions; Serial BODE index

Indexed keywords

AGED; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AGED; BODY MASS INDEX; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LONGITUDINAL STUDIES; MALE; OXYGEN CONSUMPTION; PATIENT READMISSION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX;

EID: 78651407705     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2010.06.022     Document Type: Article

References (35)

1. A.S. Buist, M.A. McBurnie, W.M. Vollmer, S. Gillespie, P. Burney, and D.M. Mannino International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study Lancet 370 2007 741 750
2. F.W. Ko, D.S. Hui, and C.K. Lai Worldwide burden of COPD in high- and low-income countries. Part III. Asia-Pacific studies Int J Tuberc Lung Dis 12 2008 713 717
3. F.W. Ko, J. Woo, W. Tam, C.K. Lai, J. Ngai, and T. Kwok Prevalence and risk factors of airflow obstruction in an elderly Chinese population Eur Respir J 32 2008 1472 1478
4. M. Chan-Yeung, C.K. Lai, K.S. Chan, A.H. Cheung, T.J. Yao, and A.S. Ho The burden of lung disease in Hong Kong: a report from the Hong Kong thoracic society Respirology 13 Suppl. 4 2008 S133 S165
5. D.M. Mannino, and S. Braman The epidemiology and economics of chronic obstructive pulmonary disease Proc Am Thorac Soc 4 2007 502 506
6. T. Darkow, P.J. Kadlubek, H. Shah, A.L. Phillips, and J.P. Marton A retrospective analysis of disability and its related costs among employees with chronic obstructive pulmonary disease J Occup Environ Med 49 2007 22 30
7. D.A. Mahler, and C.K. Wells Evaluation of clinical methods for rating dyspnea Chest 93 1988 580 586
8. B.R. Celli, C.G. Cote, J.M. Marin, C. Casanova, M. Montes de Oca, and R.A. Mendez The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease N Engl J Med 350 2004 1005 1012
9. 1 Respir Med 102 Suppl. 1 2008 S27 S35
10. K.C. Ong, A. Earnest, and S.J. Lu A multidimensional grading system (BODE index) as predictor of hospitalization for COPD Chest 128 2005 3810 3816
11. J.M. Marin, S.J. Carrizo, C. Casanova, P. Martinez-Camblor, J.B. Soriano, A.G. Agusti, and B.R. Celli Prediction of risk of COPD exacerbations by the BODE index Respir Med 103 2009 373 378
12. F.J. Martinez, G. Foster, J.L. Curtis, G. Criner, G. Weinmann, and A. Fishman Predictors of mortality in patients with emphysema and severe airflow obstruction Am J Respir Crit Care Med 173 2006 1326 1334
13. F.J. Martinez, M.K. Han, A.C. Andrei, R. Wise, S. Murray, and J.L. Curtis Longitudinal change in the BODE index predicts mortality in severe emphysema Am J Respir Crit Care Med 178 2008 491 499
14. National Heart, Lung and Blood Institute Global Initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease 2008 World Health Organization Updated 2008
15. D.E. O'Donnell, S. Aaron, J. Bourbeau, P. Hernandez, D.D. Marciniuk, and M. Balter Canadian thoracic society recommendations for management of chronic obstructive pulmonary disease -2007 update Can Respir J 14 Suppl. B 2007 5B 32B
16. T.A. Seemungal, G.C. Donaldson, E.A. Paul, J.C. Bestall, D.J. Jeffries, and J.A. Wedzicha Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 157 1998 1418 1422
17. I.S. Patel, T.A. Seemungal, M. Wilks, S.J. Lloyd-Owen, G.C. Donaldson, and J.A. Wedzicha Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations Thorax 57 2002 759 764
18. F.W. Ko, M. Ip, P.K. Chan, J.P. Fok, M.C. Chan, and J.C. Ngai A 1-year prospective study of the infectious etiology in patients hospitalized with acute exacerbations of COPD Chest 131 2007 44 52
19. F.W. Ko, M. Ip, P.K. Chan, M.C. Chan, K.W. To, and S.S. Ng Viral etiology of acute exacerbations of chronic obstructive pulmonary disease in Hong Kong Chest 132 2007 900 908
20. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383
21. Standardization of Spirometry 1994 Update. American thoracic society Am J Respir Crit Care Med 152 1995 1107 1136
22. M.S. Ip, F.W. Ko, A.C. Lau, W.C. Yu, K.S. Tang, and K. Choo Updated spirometric reference values for adult Chinese in Hong Kong and implications on clinical utilization Chest 129 2006 384 392
23. American Thoracic Society ATS statement: guidelines for the six-minute walk test Am J Respir Crit Care Med 166 2002 111 117
24. D.R. Cox Regression models and lifetables J R Stat Soc [B] 34 1972 187 220
25. M. Miravitlles, C. Murio, G. Tirado-Conde, G. Levy, H. Muellerova, and J. Soriano Geographic differences in clinical characteristics and management of COPD: the EPOCA study Int J Chron Obstruct Pulmon Dis 3 2008 1 12
26. G.C. Donaldson, T.A. Seemungal, A. Bhowmik, and J.A. Wedzicha Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease Thorax 57 2002 847 852
27. S. Sethi Bacteria in exacerbations of chronic obstructive pulmonary disease: phenomenon or epiphenomenon? Proc Am Thorac Soc 1 2004 109 114
28. J.A. Wedzicha Role of viruses in exacerbations of chronic obstructive pulmonary disease Proc Am Thorac Soc 1 2004 115 120
29. F.W. Ko, M. Ip, P.K. Chan, S.S. Ng, S.S. Chau, and D.S. Hui A one-year prospective study of infectious etiology in patients hospitalized with acute exacerbations of COPD and concomitant pneumonia Respir Med 102 2008 1109 1116
30. H.R. Anderson, C. Spix, S. Medina, J.P. Schouten, J. Castellsague, and G. Rossi Air pollution and daily admissions for chronic obstructive pulmonary disease in 6 European cities: results from the APHEA project Eur Respir J 10 1997 1064 1071
31. F.W. Ko, W. Tam, T.W. Wong, D.P. Chan, A.H. Tung, and C.K. Lai Temporal relationship between air pollutants and hospital admissions for chronic obstructive pulmonary disease in Hong Kong Thorax 62 2007 780 785
32. E.F. Wouters, D.S. Postma, B. Fokkens, W.C. Hop, J. Prins, and A.F. Kuipers Withdrawal of fluticasone propionate from combined salmeterol/ fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial Thorax 60 2005 480 487
33. G.C. Donaldson, T. Seemungal, D.J. Jeffries, and J.A. Wedzicha Effect of temperature on lung function and symptoms in chronic obstructive pulmonary disease Eur Respir J 13 1999 844 849
34. D.E. Niewoehner, Y. Lokhnygina, K. Rice, W.G. Kuschner, A. Sharafkhaneh, G.A. Sarosi, P. Krumpe, K. Pieper, and S. Kesten Risk indexes for exacerbations and hospitalizations due to COPD Chest 131 2007 20 28
35. S.T. Holgate Priorities for respiratory research in the UK Thorax 62 2007 5 7